Top 50 Life Science Startup Investors in Asia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Prox Ventures
VC Fund
|
9 | China, United States, United Kingdom | Seed, Series A | Medical, Biotechnology, Health Care | $1.9M–$28M |
|
Hillhouse Investment
VC Fund
|
6 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Mitsubishi UFJ Capital
VC Fund
|
6 | Japan, United States, Singapore | Series A, Series B | Information Technology, Software, Health Care | $2M–$369M |
|
Qiming Venture Partners
VC Fund
|
6 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
Linear Capital
VC Fund
|
5 | China, Singapore, Switzerland | Seed, Angel, Series A | Artificial Intelligence, Software, Manufacturing | $1.4M–$122M |
|
HSG
VC Fund
|
5 | China, United States, Hong Kong | Series A, Series B, Series C | Health Care, Biotechnology, Software | $4.4M–$214M |
|
SMBC Venture Capital
VC Fund
|
5 | Japan, United States, Singapore | Series A, Series B | Information Technology, Health Care, Software | $4.5M–$425M |
|
Baidu Ventures
VC Fund
|
4 | China, United States, Singapore | Series A, Seed, Series B | Artificial Intelligence, Health Care, Biotechnology | $1.4M–$145M |
|
Nissay Capital
VC Fund
|
4 | Japan, United States, Ethiopia | Seed, Series A | Health Care, Information Technology, Medical | $709k–$71M |
|
UntroD Capital
VC Fund
|
4 | Japan, Singapore, Austria | Seed, Series A | Manufacturing, Biotechnology, Medical | $2.1M–$241M |
|
Miyako Capital
VC Fund
|
4 | Japan, United States, United Kingdom | Series A, Seed, Series B | Medical, Biotechnology, Information Technology | $5.6M–$3B |
|
Osaka University Venture Capital
VC Fund
|
4 | Japan | Seed, Series A | Biotechnology, Health Care, Manufacturing | $7.1M–$142M |
|
Huagai Capital
VC Fund
|
4 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$90M |
|
EFung Capital
VC Fund
|
4 | China, United States, India | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $1.4M–$87M |
|
CITIC Capital Holdings
VC Fund
|
3 | China, United States, Japan | Series A, Series B, Series C | Manufacturing, Health Care, E-Commerce | $2.8M–$230M |
|
Hillhouse Ventures
VC Fund
|
3 | China, Singapore, Norway | Series A, Series B, Seed | Manufacturing, Biotechnology, Health Care | $10M–$120M |
|
CD Capital
VC Fund
|
3 | China, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.4M–$34M |
|
Senshu Ikeda Capital
VC Fund
|
3 | Japan | Series A, Seed | Software, Manufacturing, Internet | $1M–$142M |
|
Legend Capital
VC Fund
|
3 | China, United States, South Korea | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $2.8M–$200M |
|
Mizuho Capital
VC Fund
|
3 | Japan, United States, China | Series A, Series B | Information Technology, Software, Internet | $2.7M–$553M |
|
Angel Bridge
VC Fund
|
3 | Japan | Series A, Seed | Information Technology, Software, Consulting | $746k–$170M |
|
Northern Light Venture Capital
VC Fund
|
3 | China, United States, South Korea | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.3M–$100M |
|
Nippon Venture Capital
VC Fund
|
3 | Japan, United States, Indonesia | Series A, Series B | Software, Health Care, Medical | $3M–$269M |
|
SBI Investment
VC Fund
|
3 | Japan, South Korea, United States | Series B, Series A | Information Technology, Software, Financial Services | $4M–$283M |
|
WuXi AppTec
VC Fund
|
3 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Keio Innovation Initiative
VC Fund
|
3 | Japan, United Kingdom | Series A, Seed | Health Care, Medical, Biotechnology | $1.5M–$213M |
|
ZSVC
VC Fund
|
3 | China, United States, India | Series A, Seed, Series B | Manufacturing, Medical, Health Care | $1.4M–$85M |
|
Entrepreneurship Relay Group
VC Fund
|
3 | China | Series A, Angel | Manufacturing, Software, Enterprise | $222k–$27M |
|
Vinno Capital
VC Fund
|
3 | China, United States | Series A, Series B, Seed | Manufacturing, Semiconductor, Hardware | $1.4M–$142M |
|
JAFCO
VC Fund
|
3 | Japan, United States, Israel | Series A, Series B | Information Technology, Software, Artificial Intelligence | $2.7M–$298M |
|
MiraclePlus
VC Fund
|
3 | China, United States, Singapore | Seed, Angel, Pre-Seed | Artificial Intelligence, Software, Information Technology | |
|
Anzu Partners
VC Fund
|
3 | United States, Canada, Spain | Series A, Series B | Biotechnology, Software, Manufacturing | |
|
Tianjin Venture Capital
VC Fund
|
3 | China, United States | Seed, Series A | Manufacturing, Information Technology, Biotechnology | $202k–$28M |
|
ASBV
VC Fund
|
3 | China, Australia, Hong Kong | Seed, Series A, Angel | Health Care, Medical, Biotechnology | $425k–$31M |
|
ULTIMA
VC Fund
|
3 | China | Angel, Series A | Hardware, Software, Agriculture | $1.6M–$14M |
|
BioVenture
VC Fund
|
3 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.9M–$73M |
|
DG Daiwa Ventures
VC Fund
|
3 | Japan, United States, India | Seed, Series A | FinTech, Software, Internet | $679k–$142M |
|
Lenovo Capital and Incubator Group (LCIG)
VC Fund
|
3 | China, Hong Kong, United States | Series A, Seed, Series B | Manufacturing, Artificial Intelligence, Software | $2.8M–$145M |
|
Shangshi Fund
VC Fund
|
2 | China | Series A, Angel, Series B | Information Technology, Hardware, Electronics | |
|
Eisai
VC Fund
|
2 | Japan, United States, China | Series A, Series C | Biotechnology, Health Care, Medical | |
|
Alibaba Entrepreneurs Fund
VC Fund
|
2 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
Med-Fine Capital
VC Fund
|
2 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.8M–$60M |
|
Real Tech Japan
VC Fund
|
2 | Japan, Singapore, Austria | Series A, Seed | Manufacturing, Biotechnology, Medical | $5M–$241M |
|
Sherpa Healthcare Partners
VC Fund
|
2 | China, United States, Kenya | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.8M–$156M |
|
Shunwei Capital
VC Fund
|
2 | China, United States, India | Series A, Series B, Series C | Manufacturing, Software, Internet | $1.4M–$130M |
|
Lilly Asia Ventures
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $14M–$259M |
|
Zoo Capital
VC Fund
|
2 | China, Hong Kong, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Biotechnology | |
|
OrbiMed
VC Fund
|
2 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Loyal Valley Capital
VC Fund
|
2 | China, United States, Hong Kong | Series C, Series A, Series B | Biotechnology, Health Care, Pharmaceutical | $2.7M–$300M |
|
ANRI
VC Fund
|
2 | Japan, United States, India | Seed, Series A | Software, Health Care, Information Technology | $1M–$624M |
| Access all 50 investors in Asia Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: China, United States, United Kingdom
Investor stats
- Total investments: 76
- Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- DotBio — DotBio is a biopharmaceutical company specialized in next-generation domain antibody therapies.
- Coastar Therapeutics — Coastar Therapeutics develops an erythrocyte enveloped virus delivery technology platform to perform repeated virus dosing. It evades recognition and attack by the immune system to address the challenges of systemic and repeated administration of drug therapies. Coastar's process technology and “red blood cell membranes only” enable thecompany to overcome the challenges of mass production and standardization, and has cost advantages. The company's first product targets oncolytic viruses and is developing ELCV solutions for other therapies.The company was founded in 2017 and is based in San Diego, CAlifornia.
- Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 500
- Round size: Series A $2M–$113M; Series B $5.7M–$369M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Emium — Emium creates an infrastructure that will be a driving force in dental care and dental technology.
- Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
- Willbox — Willbox is an international logistics company providing an international logistics digital platform for shippers and logistics companies. The company's platform "Giho" connects shippers and logistics companies (transportation, packaging, warehousing, customs clearance, etc.) with a direct contract. It visualizes the three elements of[lead time, money, and safety], which have been regarded as a black box, and supports comparative examination and decision making. Willbox digitizes the packing technique of wooden boxes and steel, mandatory for international logistics, and incorporated them into their system. Their mission is to solve the logistics issues focusing on the large cargo of industrial products.The company was founded in 2019 and is based in Yokohama-shi, Kanagawa.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 740
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Plum — Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
- Bytelumio — Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
- Guangjing Energy — Guangjing Energy is a perovskite solar cell module developer, dedicated to the R&D of long-life large-area perovskite solar cell modules.
Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Manufacturing
- Stage:Seed, Angel, Series A
- Geography: China, Singapore, Switzerland
Investor stats
- Total investments: 85
- Round size: Seed $1.4M–$120M; Angel $1.4M–$122M; Series A $5.7M–$50M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $500M in 2021
Portfolio highlights
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
- Juehua Medical — Juehua Medical is a medical technology company focusing on the field of visual health.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
We help founders build enduring companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 751
- Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Series A, Series B
- Geography: Japan, United States, Singapore
Investor stats
- Total investments: 513
- Round size: Series A $4.5M–$170M; Series B $5.7M–$425M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Letara — Letara operates a space technology platform with the intention to serve a logistics network covering the solar system. The company produces hybrid propulsion engines for small spacecraft, promoting groundbreaking advances in space propulsion with high thrust, safe, and inexpensive propulsion system technology.
- Pragtech — Pragtech develops and operates parking lot service software that helps to eliminate payment congestion and reduce operating costs.
- Metro Weather — Metroweather is a venture from Kyoto University that develops a high-performance Doppler lidar that measures the direction and speed of wind several tens of kilometers away from minute movements of fine particles in the atmosphere. We aim to contribute to the safety of the sky by completing a three-dimensional wind map, which has never beenrealized,based on years of research at the Kyoto University Research Institute for Sustainable Areas.
Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, United States, Singapore
Investor stats
- Total investments: 207
- Round size: Seed $1.9M–$14M; Series A $1.4M–$42M; Series B $8M–$145M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
- Enze Kangtai — Exosome products, reagents, services, and platform capabilities.
- Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Japan, United States, Ethiopia
Investor stats
- Total investments: 239
- Round size: Seed $709k–$43M; Series A $2.7M–$71M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
- Castee — Castee provides social collaboration services and also helps with a tool for job requests and overseas projects for creators.
- 3S — 3S is a SaaS developer platform that provides and operates 24-hour home nursing care services through technology.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 124
- Round size: Seed $3.2M–$43M; Series A $2.1M–$241M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
- Illumi Medical — Illumi Medical is a manufacturing company that produces medical equipment and devices for the healthcare sector.
- Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more...Investment focus
- Industry: Medical, Biotechnology, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Japan, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $5.6M–$118M; Series A $6.1M–$70M; Series B $99M–$3B
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2019
Portfolio highlights
- Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
- VLP Therapeutics — VLP Therapeutics, LLC (VLP) was established in 2012 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. Its vision is to combat the 21st century global public health problems through revolutionary nextgeneration i-αVLP (inserted alpha VLP) Technology. The company is headquartered in Gaithersburg, Maryland
- XFOREST Therapeutics — xFOREST Therapeutics develops a drug discovery platform that targets RNA structures.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Japan
Investor stats
- Total investments: 79
- Round size: Seed $7.1M–$99M; Series A $16M–$142M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- QunaSys — Quantum physics is a relatively new field built since the beginning of the 20th century, but we have used MRI (nuclear magnetic resonance equipment) and lasers used for close examinations in hospitals, and semiconductors mounted on computers. Supports the technology that supports the daily life of people.QunaSys was established to bring out thequantum physics that has been active behind the scenes to the front stage, and to make use of quantum properties to realize technologies that could not be achieved with existing technologies.
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 133
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
- GenFleet Therapeutics — GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize thebody's own immune system.
- MicuRx Pharmaceuticals — MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 67
- Round size: Series A $1.4M–$76M; Series B $14M–$87M; Series C $14M–$71M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more...Investment focus
- Industry: Manufacturing, Health Care, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: China, United States, Japan
Investor stats
- Total investments: 99
- Round size: Series A $3M–$230M; Series B $2.8M–$50M; Series C $4.3M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $2.8B in 2018
Portfolio highlights
- NEON — Discover a global experience entertainment company specialising in unique, immersive and large-scale experiences held all around the world, all year round.
- Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series A, Series B, Seed
- Geography: China, Singapore, Norway
Investor stats
- Total investments: 71
- Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
- Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
- HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 69
- Round size: Seed $1.4M–$14M; Series A $1.4M–$32M; Series B $7.1M–$34M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Pipi Bear —
- Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Senshu Ikeda Capital offers financial consultancy services.
Show more...Investment focus
- Industry: Software, Manufacturing, Internet
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $1M–$61M; Series A $1.9M–$142M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — raised $177M in 2019
Portfolio highlights
- TSK Corporation —
- Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
- New Innovations — New Innovations company is offering a snuggling service to many people who support Japan's “high quality”. AI and robots do not take away the job, but robots support the work that is accomplished without the involvement of people, and many working people are aiming for the future to create a more humanoid life. With the problem of lack oftalent, it was difficult to reflect technology on OFF Line until now, trying to provide robots in the “food and drink” and “retail” industry, CEKAI's first demand forecast AI unmanned cafeThe robot “√C” was developed. √C is not “looking for coffee that suits me”, but instead realizes “coffee is perfect for me” with demand forecasting AI. Today, people who drink coffee are choosing their favorite cafe, canned coffee, convenience store coffee, etc., according to their taste needs, SPEED needs, and hospitality needs. The company developed the service as a new choice of coffee, and in the future, the perfect coffee according to the taste preferences, busy, physical condition and mood of the day., which aims to provide. In July 2019, the company receives a third party quota increase of 70 million yen from Zashid Capital and DEEPCORE. From August 1, 2019, with the cooperation of Nankai Electric Railway, “√C” will be installed at Namba Station/Namba Skyo, and demonstration experiments will begin.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: China, United States, South Korea
Investor stats
- Total investments: 388
- Round size: Series A $2.8M–$94M; Series B $12M–$113M; Series C $14M–$200M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $177M in 2021
Portfolio highlights
- Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
- ESWIN Computing — ESWIN Computing provides research and development of RISC-V computing architecture.
- Yosemite Clinic — Yosemite Clinic is a full-service clinic providing convenient walk-in medical services in a state-of-the-art environment in Central Pudong. They offer family medicine, internal medicine, surgery, orthopedics (sports medicine), dermatology, medical cosmetology, dentistry, gynecology, pediatrics, ophthalmology, anesthesiology, rehabilitationmedicine, medical imaging, laboratory, pharmacy and more. Their onsite facilities and equipment include CT, X-ray, Ultrasound, Laboratory and Operating Rooms. Their doctors come from China and across the world, enabling us to serve you in many languages including, English, Japanese, Malay, Mandarin Chinese and Cantonese.
Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.
Show more...Investment focus
- Industry: Information Technology, Software, Internet
- Stage:Series A, Series B
- Geography: Japan, United States, China
Investor stats
- Total investments: 439
- Round size: Series A $2.7M–$156M; Series B $5.2M–$553M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- Logiless — Logiless is a cloud type all-in-one software dedicated to net shop. Since both orders and stocks can be managed together in a logical manner, efficiency of operations can be realized at low cost.
- LUC — LUC is a provider of the AI x experience analysis platform "TERUS," .
- Turing — Turing develops and manufactures fully autonomous vehicles.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.
Show more...Investment focus
- Industry: Information Technology, Software, Consulting
- Stage:Series A, Seed
- Geography: Japan
Investor stats
- Total investments: 64
- Round size: Seed $2.2M–$113M; Series A $746k–$170M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $152M in 2019
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- Plainer — Plainer is an IT company that provides software development, data management, and SaaS solutions.
- CraftBank — CraftBank, Inc. is the start-up that operates online matching platform between constructors with having relations with 22k specialty constructors (10% coverage in the market). The company was succeeded in Management BuyOut in April 2021.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, South Korea
Investor stats
- Total investments: 240
- Round size: Seed $1.3M–$100M; Series A $4.3M–$40M; Series B $11M–$62M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
- RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
- Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Series B
- Geography: Japan, United States, Indonesia
Investor stats
- Total investments: 163
- Round size: Series A $3M–$85M; Series B $7.7M–$269M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $278M in 2023
Portfolio highlights
- Gecipe — Gecipe is a video service for e-sports players.
- Issues — Issues provides development and management of web service issues that solve the problems.
- SecureNavi — SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more...Investment focus
- Industry: Information Technology, Software, Financial Services
- Stage:Series B, Series A
- Geography: Japan, South Korea, United States
Investor stats
- Total investments: 350
- Round size: Series A $4M–$170M; Series B $6.5M–$283M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $1.1B in 2020
Portfolio highlights
- LQUOM — QWAVE offers cryptography communication technology.
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
- Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Japan, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $1.5M–$213M; Series A $7.4M–$155M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $1.4B in 2020
Portfolio highlights
- ElleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- Aeterlink — Aeterlink is a wireless device maker and developer. They applied their technology to fields such as FA, robots, smart houses, and medicine and developed practical level technologies such as elemental technology that can wirelessly supply power.
- Metagen Therapeutics — Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more...Investment focus
- Industry: Manufacturing, Medical, Health Care
- Stage:Series A, Seed, Series B
- Geography: China, United States, India
Investor stats
- Total investments: 136
- Round size: Seed $1.4M–$4M; Series A $1.4M–$16M; Series B $2.8M–$85M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Zhicheng AI — Zhicheng AI is a developer of general-purpose artificial intelligence robots, dedicated to designing and building intelligent robotic systems that integrate advanced AI algorithms, perception technologies, and adaptive learning capabilities
- Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
- Sunseeker — Sunseeker Power Equipment specializes in the manufacturing and supplying of garden tools, focusing on innovation in the realm of outdoor power equipment. The product range includes robotic lawn mowers, cordless Li-ion battery-powered tools, and petrol-powered equipment, catering to both garden and agricultural needs. The brand emphasizes onproviding solutions that enhance efficiency and ease of use in maintaining outdoor spaces. Sunseeker Power Equipment's offerings are designed to meet the demands of a global market, with a significant emphasis on exporting their products under the brand name 'SUNSEEKER 山科'. The company's portfolio extends to engines and a variety of garden tools series, showcasing a commitment to diversifying and expanding its product lineup to address the evolving needs of its customers.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more...Investment focus
- Industry: Manufacturing, Software, Enterprise
- Stage:Series A, Angel
- Geography: China
Investor stats
- Total investments: 24
- Round size: Series A $222k–$27M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more...Investment focus
- Industry: Manufacturing, Semiconductor, Hardware
- Stage:Series A, Series B, Seed
- Geography: China, United States
Investor stats
- Total investments: 34
- Round size: Series A $1.4M–$14M; Series B $11M–$142M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Glazero Technology — Established in Dec 2020, Glazero is a brand that provides smart home solutions to global markets. It focuses on AIot smart home products, covering smart security, smart lighting and smart cleaning products. Glazero starts from the North American home appliance market, and sells through cross-border e-commerce platforms.
- Feibao Intelligent — Feibao is a high-tech enterprise that uses core technology to create a "specialized vehicle operation platform for garbage sorting and transportation". The company adheres to the core values of "willing to learn, proficient in efficiency; brave in innovation and detail", insists on R&D innovation and talent training, andpays attention to the ultimate customer service experience.
- Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B
- Geography: Japan, United States, Israel
Investor stats
- Total investments: 271
- Round size: Series A $2.7M–$255M; Series B $6.4M–$298M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Plott — Plott producing youtube animation platform under Vision “Become a Content holder from YouTube”. In August 2019, the company name was changed from Fabo to Plott. Plott, the new company name, is derived from the plot that you make before writing novels, etc., and the idea that “I want to make content all the time” is put in the company name.
- Sharing Energy — Sharing Energy is providing energy supply and energy management services.
- The Chain Museum — The Chain Museum creates a platform for connecting individuals .
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: China, United States, Singapore
Investor stats
- Total investments: 76
- Lead/follow: no public data
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Series A, Series B
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 75
- Lead/follow: no public data
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
- CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
Tianjin Venture Capital is an investment firm.
Show more...Investment focus
- Industry: Manufacturing, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: China, United States
Investor stats
- Total investments: 104
- Round size: Seed $413k–$15M; Series A $202k–$28M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
- JGene Biotechnology — JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recentlyreceived angel round investment.
ASBV focuses on early and mid-term venture capital investments.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Angel
- Geography: China, Australia, Hong Kong
Investor stats
- Total investments: 27
- Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
ULTIMA is an investment management firm.
Show more...Investment focus
- Industry: Hardware, Software, Agriculture
- Stage:Angel, Series A
- Geography: China
Investor stats
- Total investments: 4
- Round size: Series A $1.6M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 165
- Round size: Seed $7.1M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
- Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.
Show more...Investment focus
- Industry: FinTech, Software, Internet
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 71
- Round size: Seed $679k–$26M; Series A $4M–$142M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Fivot — Fivot is a financial company that provides venture capital, financing, credit, money lending, and prepaid payment services.
- digzyme — Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
- Zehitomo — Zehitomo is an Japanese online platform that enables user to hire local service professionals, from photographers to personal trainers.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more...Investment focus
- Industry: Manufacturing, Artificial Intelligence, Software
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 227
- Round size: Seed $7M–$65M; Series A $2.8M–$73M; Series B $5.5M–$145M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $500M in 2016
Portfolio highlights
- Nyonic — Nyonic develops breakthrough AI technology to tackle difficult obstacles for businesses and is committed to developing a leading SOTA (state-of-the-art) basic model as well as an industry-leading, high-performance vertical model.
- Lanxin Computing — Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
- SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
Shangshi Fund is an investment firm.
Show more...Investment focus
- Industry: Information Technology, Hardware, Electronics
- Stage:Series A, Angel, Series B
- Geography: China
Investor stats
- Total investments: 50
- Lead/follow: no public data
Portfolio highlights
- HurRain NanoTech — HurRain NanoTech is a new functional nanomaterials service provider for atmospheric water generation solutions. It developed a platform for material screening and amplification with functional composite moisture-absorbing interfacial thermal materials as the primary R&D direction, created a product line of atmospheric water generator devicesand interfacial thermal materials, and provided customers with standardized products and solutions.
- Wutong Sensing Control — Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics.
- Silicon Ceramics New Energy — Silicon Ceramics New Energy is a manufactures synthetic quartz sand and silicon carbide, and offers chip thermal management solutions.
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series C
- Geography: Japan, United States, China
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 78
- Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $69M in 2019
Portfolio highlights
- Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Medical
- Stage:Series A, Seed
- Geography: Japan, Singapore, Austria
Investor stats
- Total investments: 79
- Round size: Seed $5M–$43M; Series A $6M–$241M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
- Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Kenya
Investor stats
- Total investments: 99
- Round size: Series A $2.8M–$50M; Series B $14M–$100M; Series C $12M–$156M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
- Biortus — Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery.To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-rayCrystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more...Investment focus
- Industry: Manufacturing, Software, Internet
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 417
- Round size: Series A $1.4M–$41M; Series B $8.2M–$50M; Series C $20M–$130M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $1.2B in 2018
Portfolio highlights
- Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
- Z.ai — Z.ai develops artificial intelligence models and services built upon large-scale pretrained architectures. The company offers ChatGLM, a dialogue-focused language model series designed for smooth conversation and easy integration. It also provides Ying, a text-to-video model capable of generating short video clips from text or images, and AutoGLM,a voice-driven AI agent that performs smartphone tasks based on complex user instructions. Z.ai supports integration through an API platform and offers migration assistance for developers moving from other AI ecosystems. The company’s technology stems from research at Tsinghua University’s KEG lab and emphasizes general-purpose cognitive intelligence models.
- Darma — DARMA - Digital Healt
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 212
- Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
- Ronovo Surgical — Founded in 2019 and headquartered in Shanghai, Ronovo Surgical is founded by industry veterans from global leaders in surgical and industrial robotics, such as Intuitive Surgical, Johnson & Johnson, Medtronic and KUKA. Aiming to transform how surgery is performed in China, Ronovo is leveraging robust R&D capabilities and strategicpartnerships globally to accelerate the development of a broad portfolio of MIS and digital surgery solutions that exemplifies the core themes of simplicity, precision, and intelligence.
- Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 589
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Loyal Valley Capital is a thematic, research-driven private equity firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series C, Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 99
- Round size: Series A $2.7M–$170M; Series B $25M–$145M; Series C $29M–$300M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $465M in 2019
Portfolio highlights
- SeeYA Technology — SeeYA Technology is a high-tech company specializing in R&D, design, production and sales of new-generation semiconductor OLEDoS display, and providing customers with micro-display components, modules and related solutions. There is a comprehensive product line to full fill different demands from AR/VR, drones, thermal devices, nightvision equipment etc.
- Surgerii Technology — Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design andintegration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.
- Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
ANRI is a Japanese venture capital firm that mainly invests in seed and early-stage startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Japan, United States, India
Investor stats
- Total investments: 237
- Round size: Seed $1M–$94M; Series A $6.1M–$624M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- 3S — 3S is a SaaS developer platform that provides and operates 24-hour home nursing care services through technology.
- Knowledge Work — Knowledge Work specializes in the development and sales of software for companies.
- Rendez-Vous — RENDEZ-VOUS offers a co-ownership option for vintage cars.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!